198 related articles for article (PubMed ID: 17077165)
1. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
[TBL] [Abstract][Full Text] [Related]
2. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity.
Woo JH; Park JW; Lee SH; Kim YH; Lee IK; Gabrielson E; Lee SH; Lee HJ; Kho YH; Kwon TK
Cancer Res; 2003 Jun; 63(12):3430-4. PubMed ID: 12810681
[TBL] [Abstract][Full Text] [Related]
3. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.
Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH
Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731
[TBL] [Abstract][Full Text] [Related]
4. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
Huang CS; Fan YE; Lin CY; Hu ML
J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
[TBL] [Abstract][Full Text] [Related]
6. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
[TBL] [Abstract][Full Text] [Related]
7. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation.
Hannay JA; Liu J; Zhu QS; Bolshakov SV; Li L; Pisters PW; Lazar AJ; Yu D; Pollock RE; Lev D
Mol Cancer Ther; 2007 May; 6(5):1650-60. PubMed ID: 17513613
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
9. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
10. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
11. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-{kappa}B.
Tacon CE; Wiehler S; Holden NS; Newton R; Proud D; Leigh R
Am J Respir Cell Mol Biol; 2010 Aug; 43(2):201-9. PubMed ID: 19783786
[TBL] [Abstract][Full Text] [Related]
12. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
13. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
Hsiang CY; Wu SL; Chen JC; Lo HY; Li CC; Chiang SY; Wu HC; Ho TY
Toxicol Lett; 2007 Jun; 171(1-2):78-86. PubMed ID: 17543481
[TBL] [Abstract][Full Text] [Related]
14. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis.
Ko HM; Park YM; Jung B; Kim HA; Choi JH; Park SJ; Lee HK; Im SY
FEBS Lett; 2005 Apr; 579(11):2369-75. PubMed ID: 15848174
[TBL] [Abstract][Full Text] [Related]
15. Induction of matrix metalloproteinase-1 gene transcription by tumour necrosis factor alpha via the p50/p50 homodimer of nuclear factor-kappa B in activated human hepatic stellate cells.
Hozawa S; Nakamura T; Nakano M; Adachi M; Tanaka H; Takahashi Y; Tetsuya M; Miyata N; Soma H; Hibi T
Liver Int; 2008 Dec; 28(10):1418-25. PubMed ID: 19055644
[TBL] [Abstract][Full Text] [Related]
16. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
Liang JA; Wu SL; Lo HY; Hsiang CY; Ho TY
Mol Pharmacol; 2009 Jan; 75(1):151-7. PubMed ID: 18835982
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
[TBL] [Abstract][Full Text] [Related]
19. Targeting gene expression to tumor cells with loss of wild-type p53 function.
Zhu J; Gao B; Zhao J; Balmain A
Cancer Gene Ther; 2000 Jan; 7(1):4-12. PubMed ID: 10678350
[TBL] [Abstract][Full Text] [Related]
20. Dual androgen-response elements mediate androgen regulation of MMP-2 expression in prostate cancer cells.
Li BY; Liao XB; Fujito A; Thrasher JB; Shen FY; Xu PY
Asian J Androl; 2007 Jan; 9(1):41-50. PubMed ID: 16888681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]